Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 134
of 7Next
1:
Jerry DJ, Minter LM, Becker KA, Blackburn AC.
Free in PMC
Hormonal control of p53 and chemoprevention.
Breast Cancer Res. 2002;4(3):91-4. Epub 2002 Mar 26. Review.
PMID: 12052250 [PubMed - indexed for MEDLINE]
2:
Wijnhoven SW, Zwart E, Speksnijder EN, Beems RB, Olive KP, Tuveson DA, Jonkers J, Schaap MM, van den Berg J, Jacks T, van Steeg H, de Vries A.
Free Full Text
Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development.
Cancer Res. 2005 Sep 15;65(18):8166-73.
PMID: 16166291 [PubMed - indexed for MEDLINE]
3:
Russo IH, Russo J.
Abstract
Hormonal approach to breast cancer prevention.
J Cell Biochem Suppl. 2000;34:1-6. Review.
PMID: 10762007 [PubMed - indexed for MEDLINE]
4:
Franeková M, Zúbor P, Stanclová A, Dussan CA, Bohusová T, Galo S, Dobrota D, Kajo K, Péc M, Racay P.
Abstract
Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Neoplasma. 2007;54(2):155-61.
PMID: 17319790 [PubMed - indexed for MEDLINE]
5:
Wirtenberger M, Frank B, Hemminki K, Klaes R, Schmutzler RK, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D, Bartram CR, Burwinkel B.
Free Full Text
Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer.
Carcinogenesis. 2006 Aug;27(8):1655-60. Epub 2006 Feb 25.
PMID: 16501249 [PubMed - indexed for MEDLINE]
6:
Yu JC, Hsu HM, Chen ST, Hsu GC, Huang CS, Hou MF, Fu YP, Cheng TC, Wu PE, Shen CY.
Abstract
Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.
J Biomed Sci. 2006 May;13(3):419-32. Epub 2006 Feb 25.
PMID: 16502042 [PubMed - indexed for MEDLINE]
7:
Blackburn AC, Jerry DJ.
Free in PMC
Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?
Breast Cancer Res. 2002;4(3):101-11. Epub 2002 Apr 18. Review.
PMID: 12052252 [PubMed - indexed for MEDLINE]
8:
Medina D.
Free Full Text
Breast cancer: the protective effect of pregnancy.
Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):380S-4S.
PMID: 14734495 [PubMed - indexed for MEDLINE]
9:
Hamilton AS, Mack TM.
Free Full Text
Puberty and genetic susceptibility to breast cancer in a case-control study in twins.
N Engl J Med. 2003 Jun 5;348(23):2313-22.
PMID: 12788995 [PubMed - indexed for MEDLINE]
10:
Lawson JS, Tran DD, Ford C, Rawlinson WD.
Abstract
Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer.
Breast Cancer Res Treat. 2004 Sep;87(1):13-7.
PMID: 15377846 [PubMed - indexed for MEDLINE]
11:
Rodriquez E, Domchek SM.
Abstract
The prevention of hereditary breast cancer.
Semin Oncol. 2007 Oct;34(5):401-5. Review.
PMID: 17920894 [PubMed - indexed for MEDLINE]
12:
Blackburn AC, Hill LZ, Roberts AL, Wang J, Aud D, Jung J, Nikolcheva T, Allard J, Peltz G, Otis CN, Cao QJ, Ricketts RS, Naber SP, Mollenhauer J, Poustka A, Malamud D, Jerry DJ.
Free in PMC
Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk.
Am J Pathol. 2007 Jun;170(6):2030-41.
PMID: 17525270 [PubMed - indexed for MEDLINE]
13:
Grabrick DM, Vierkant RA, Anderson KE, Cerhan JR, Anderson VE, Seller TA.
Abstract
Association of correlates of endogenous hormonal exposure with breast cancer risk in 426 families (United States).
Cancer Causes Control. 2002 May;13(4):333-41.
PMID: 12074503 [PubMed - indexed for MEDLINE]
14:
Furberg H, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B.
Abstract
Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States).
Cancer Causes Control. 2003 Sep;14(7):609-18.
PMID: 14575358 [PubMed - indexed for MEDLINE]
15:
Muti P.
Abstract
The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence.
Ann N Y Acad Sci. 2004 Dec;1028:273-82. Review.
PMID: 15650252 [PubMed - indexed for MEDLINE]
16:
Goldberg JI, Borgen PI.
Abstract
Breast cancer susceptibility testing: past, present and future.
Expert Rev Anticancer Ther. 2006 Aug;6(8):1205-14. Review.
PMID: 16925486 [PubMed - indexed for MEDLINE]
17:
Boersma BJ, Howe TM, Goodman JE, Yfantis HG, Lee DH, Chanock SJ, Ambs S.
Free Full Text
Association of breast cancer outcome with status of p53 and MDM2 SNP309.
J Natl Cancer Inst. 2006 Jul 5;98(13):911-9.
PMID: 16818855 [PubMed - indexed for MEDLINE]
18:
Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM.
Free Full Text
Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Carcinogenesis. 2007 Aug;28(8):1680-6. Epub 2007 Apr 21.
PMID: 17449902 [PubMed - indexed for MEDLINE]
19:
Beckmann MW, Bani MR, Fasching PA, Strick R, Lux MP.
Abstract
Risk and risk assessment for breast cancer: molecular and clinical aspects.
Maturitas. 2007 May 20;57(1):56-60. Epub 2007 Mar 26. Review.
PMID: 17386982 [PubMed - indexed for MEDLINE]
20:
Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S.
Abstract
Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Cancer Lett. 2004 Jul 16;210(2):197-203. Erratum in: Cancer Lett. 2005 Sep 28;227(2):237.
PMID: 15183535 [PubMed - indexed for MEDLINE]
Items 1 - 20 of 134
of 7Next